| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
13,769 |
10,090 |
$1.12M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
9,696 |
6,149 |
$1.11M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,126 |
2,985 |
$312K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,523 |
7,120 |
$267K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,681 |
1,144 |
$246K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
387 |
273 |
$243K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,161 |
772 |
$213K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
615 |
414 |
$163K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,221 |
2,240 |
$132K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,826 |
1,523 |
$128K |
| 71046 |
Radiologic examination, chest; 2 views |
4,455 |
3,230 |
$110K |
| 70450 |
Computed tomography, head or brain; without contrast material |
921 |
554 |
$110K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,214 |
1,771 |
$76K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
2,012 |
547 |
$72K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,307 |
1,492 |
$64K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
845 |
476 |
$52K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,886 |
1,007 |
$50K |
| 80053 |
Comprehensive metabolic panel |
8,677 |
6,393 |
$50K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
699 |
515 |
$44K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,531 |
638 |
$43K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,527 |
7,456 |
$41K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,351 |
1,353 |
$35K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,776 |
1,172 |
$34K |
| G0378 |
Hospital observation service, per hour |
202 |
80 |
$32K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,444 |
1,211 |
$31K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
536 |
404 |
$30K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,856 |
2,341 |
$29K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
948 |
767 |
$28K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
842 |
548 |
$25K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
848 |
563 |
$21K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
905 |
777 |
$19K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
885 |
759 |
$18K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
629 |
576 |
$15K |
| 99215 |
Prolong outpt/office vis |
775 |
294 |
$14K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
596 |
415 |
$14K |
| 80061 |
Lipid panel |
1,286 |
1,142 |
$13K |
| 71045 |
Radiologic examination, chest; single view |
1,153 |
683 |
$13K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
6,238 |
5,025 |
$12K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
500 |
439 |
$11K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,649 |
1,643 |
$11K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,390 |
1,703 |
$9K |
| 80305 |
|
1,647 |
852 |
$8K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
71 |
66 |
$8K |
| H0007 |
Alcohol and/or drug services; crisis intervention (outpatient) |
109 |
59 |
$7K |
| 85027 |
|
1,837 |
1,219 |
$6K |
| 80306 |
|
868 |
483 |
$6K |
| 87088 |
|
2,390 |
1,702 |
$6K |
| 83735 |
|
2,524 |
1,417 |
$6K |
| 84484 |
|
1,864 |
993 |
$6K |
| 83690 |
|
1,588 |
1,106 |
$5K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
173 |
166 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
777 |
679 |
$5K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
37 |
36 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
9,561 |
7,010 |
$5K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
30 |
24 |
$4K |
| 86850 |
|
614 |
457 |
$4K |
| 97161 |
|
78 |
53 |
$4K |
| 72100 |
|
101 |
76 |
$4K |
| 82607 |
|
439 |
371 |
$4K |
| A4649 |
Surgical supply; miscellaneous |
60 |
39 |
$4K |
| 73030 |
|
204 |
161 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
597 |
201 |
$3K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,926 |
1,237 |
$3K |
| 97750 |
|
99 |
75 |
$3K |
| 87186 |
|
663 |
435 |
$3K |
| 82728 |
|
278 |
231 |
$3K |
| 81001 |
|
2,061 |
1,385 |
$3K |
| 87077 |
|
636 |
411 |
$3K |
| 86780 |
|
230 |
210 |
$2K |
| 80076 |
|
419 |
321 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
42 |
39 |
$2K |
| 87070 |
|
347 |
299 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
100 |
83 |
$2K |
| 85610 |
|
1,423 |
872 |
$2K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
109 |
103 |
$2K |
| 87653 |
|
80 |
76 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
41 |
34 |
$2K |
| 85730 |
|
900 |
558 |
$1K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
18 |
13 |
$1K |
| 83605 |
|
388 |
228 |
$1K |
| 83880 |
|
231 |
135 |
$1K |
| 82746 |
|
141 |
119 |
$1K |
| 85007 |
|
1,284 |
819 |
$1K |
| 73610 |
|
74 |
64 |
$1K |
| 83516 |
|
75 |
26 |
$1K |
| 85652 |
|
752 |
577 |
$1K |
| 81003 |
|
1,476 |
1,104 |
$1K |
| 84466 |
|
138 |
110 |
$1K |
| 99441 |
|
237 |
207 |
$1K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
136 |
26 |
$1K |
| 92557 |
|
88 |
69 |
$1K |
| 86140 |
|
284 |
217 |
$1K |
| 87340 |
|
128 |
109 |
$949.03 |
| 86762 |
|
87 |
73 |
$932.66 |
| 86901 |
|
577 |
419 |
$932.27 |
| 86900 |
|
577 |
419 |
$929.75 |
| 83540 |
|
200 |
163 |
$916.29 |
| 99238 |
Hospital discharge day management, 30 minutes or less |
39 |
27 |
$809.64 |
| 59025 |
Fetal non-stress test |
24 |
14 |
$789.56 |
| 95806 |
|
15 |
12 |
$738.00 |
| 86803 |
|
75 |
71 |
$736.40 |
| 81025 |
|
172 |
130 |
$727.45 |
| 84703 |
|
139 |
110 |
$677.09 |
| 81002 |
|
292 |
243 |
$657.98 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
103 |
66 |
$633.95 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
26 |
25 |
$460.88 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
22 |
19 |
$424.63 |
| 95117 |
|
38 |
12 |
$387.52 |
| H0004 |
Behavioral health counseling and therapy, per 15 minutes |
79 |
42 |
$386.96 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
23 |
12 |
$372.62 |
| J2704 |
Injection, propofol, 10 mg |
20 |
12 |
$369.66 |
| 82950 |
|
82 |
77 |
$331.48 |
| 97535 |
Self-care/home management training, each 15 minutes |
19 |
15 |
$328.30 |
| 87807 |
|
41 |
34 |
$326.71 |
| 99239 |
Hospital discharge day management, more than 30 minutes |
24 |
12 |
$242.87 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
14 |
13 |
$220.27 |
| H0005 |
Alcohol and/or drug services; group counseling by a clinician |
69 |
43 |
$200.00 |
| 73110 |
|
58 |
37 |
$198.52 |
| 51798 |
|
21 |
12 |
$197.08 |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
22 |
13 |
$175.13 |
| 73564 |
|
32 |
27 |
$156.40 |
| 73130 |
|
52 |
49 |
$140.02 |
| 84439 |
|
22 |
12 |
$136.08 |
| 92556 |
|
14 |
12 |
$135.00 |
| 80050 |
General health panel |
14 |
14 |
$108.22 |
| 99442 |
|
30 |
15 |
$106.38 |
| 87081 |
|
27 |
12 |
$92.50 |
| 87040 |
|
34 |
12 |
$74.44 |
| 92567 |
|
14 |
13 |
$68.25 |
| 92552 |
|
14 |
12 |
$67.50 |
| V5266 |
Battery for use in hearing device |
17 |
12 |
$63.00 |
| 73630 |
|
14 |
12 |
$56.29 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
15 |
13 |
$30.82 |
| 99051 |
|
156 |
116 |
$29.25 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
422 |
378 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
27 |
14 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
26 |
13 |
$0.00 |